[Uric acid as a risk factor for cardiovascular diseases]
Vnitrni Lekarstvi
|January 28, 2017
Summary
High uric acid levels are linked to obesity, metabolic syndrome, and cardiovascular diseases, acting as an independent risk factor. However, current evidence does not support treating hyperuricemia to reduce cardiovascular risk.
Area of Science:
- Cardiovascular Medicine
- Metabolic Health
- Clinical Biochemistry
Background:
- Uric acid is increasingly recognized for its role in the pathogenesis of metabolic and cardiovascular diseases.
- Elevated uric acid is an independent risk factor for morbidity and mortality.
- The precise relationship between uric acid and cardiovascular disease (direct vs. indirect) remains under investigation.
Purpose of the Study:
- To elucidate the relationship between uric acid and key cardiovascular risk factors.
- To review the current understanding of uric acid's role in metabolic syndrome, obesity, and hypertension.
Main Methods:
- Literature review and synthesis of existing research on uric acid and cardiovascular risk factors.
- Analysis of the interplay between fructose metabolism, insulin resistance, and uric acid levels.
Main Results:
- Uric acid is implicated in the development of obesity, metabolic syndrome, and cardiovascular diseases.
- The association between uric acid and cardiovascular disease may be direct (e.g., endothelial dysfunction) or indirect (mediated by metabolic factors).
- Key risk factors discussed include fructose intake, insulin resistance, metabolic syndrome, and visceral obesity.
Conclusions:
- While uric acid is associated with cardiovascular risk factors, its direct causal role and the benefits of its reduction for cardiovascular outcomes require further research.
- Current evidence is insufficient to recommend hyperuricemia treatment solely for decreasing cardiovascular risk.
Related Concept Videos
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
681
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
681
Urinary Tract Calculi I: Introduction
661
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
661
Coronary Artery Disease IV: Preventive Measures
789
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Atherosclerosis III: Management
540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
504
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
504
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)

